Clinical Trials Browser

Phase 2 × fimepinostat × Endocrine × Clear all

NCT05971758 2025-07-04

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Phase 2 Recruiting

Pituitary ACTH Hypersecretion